Literature DB >> 12914719

Obesity and cardiovascular risk.

A M Sharma1.   

Abstract

In most industrialized countries, 40-60% of the population is now overweight or obese. Obesity has recently been recognized as a major modifiable risk factor for cardiovascular disease, second only to cigarette smoking. Excess weight and obesity markedly increase the risk for hypertension, diabetes, coronary artery disease and congestive heart failure in both men and women. Populations most severely affected include the poor, the uneducated and certain racial and ethnic groups. Obesity is currently classified based on body mass index (BMI), but measurement of waist circumference as an important determinant of cardiovascular and metabolic risk is receiving increasing acceptance. For moderate overweight and obesity, interventions include dietary modification, increasing physical activity, behavior therapy and pharmacotherapy. Surgery is currently the only viable approach to morbid obesity.

Entities:  

Mesh:

Year:  2003        PMID: 12914719     DOI: 10.1016/s1096-6374(03)00047-9

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  12 in total

Review 1.  Vasodilator signals from perivascular adipose tissue.

Authors:  Maik Gollasch
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

2.  Association of carotid intima-media thickness and cardiovascular risk factors in women pre- and post-bariatric surgery.

Authors:  P L F A Sarmento; F L Plavnik; M T Zanella; P E Pinto; R B Miranda; S A Ajzen
Journal:  Obes Surg       Date:  2008-12-13       Impact factor: 4.129

3.  Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study.

Authors:  Christin C Rogers; Rita R Alloway; J Wesley Alexander; Michael Cardi; Jennifer Trofe; Alexander A Vinks
Journal:  Clin Transplant       Date:  2008 May-Jun       Impact factor: 2.863

4.  Morphological Changes in the Carotid Artery Intima after Gastric Bypass for Morbid Obesity.

Authors:  Federico Marchesi; Roberto Giacosa; Valeria Reggiani; Giuseppina De Sario; Francesco Tartamella; Elisa Melani; Maria Teresa Mita; Francesco Giovanni Cinieri; Stefano Cecchini; Matteo Ricco'; Pierfranco Salcuni; Luigi Roncoroni
Journal:  Obes Surg       Date:  2017-02       Impact factor: 4.129

5.  The effect of ferulic acid ethyl ester on leptin-induced proliferation and migration of aortic smooth muscle cells.

Authors:  Yung-Chieh Tsai; Yen-Mei Lee; Chih-Hsiung Hsu; Sy-Ying Leu; Hsiao-Yen Chiang; Mao-Hsiung Yen; Pao-Yun Cheng
Journal:  Exp Mol Med       Date:  2015-08-28       Impact factor: 8.718

6.  Relationship between Body Mass Index (BMI) and body fat percentage, estimated by bioelectrical impedance, in a group of Sri Lankan adults: a cross sectional study.

Authors:  Chathuranga Ranasinghe; Prasanna Gamage; Prasad Katulanda; Nalinda Andraweera; Sithira Thilakarathne; Praveen Tharanga
Journal:  BMC Public Health       Date:  2013-09-03       Impact factor: 3.295

7.  The preparation of capsaicin-chitosan microspheres (CCMS) enteric coated tablets.

Authors:  Jian Chen; Gui-Dong Huang; Si-Rong Tan; Jiao Guo; Zheng-Quan Su
Journal:  Int J Mol Sci       Date:  2013-12-13       Impact factor: 5.923

8.  Weight gain, overweight and obesity in solid organ transplantation--a study protocol for a systematic literature review.

Authors:  Sonja Beckmann; Nataša Ivanović; Gerda Drent; Todd Ruppar; Sabina De Geest
Journal:  Syst Rev       Date:  2015-01-06

9.  MicroRNA regulation of adipose derived stem cells in aging rats.

Authors:  Jia Fei; Holly Tamski; Carla Cook; Nalini Santanam
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

10.  Genistein suppresses leptin-induced proliferation and migration of vascular smooth muscle cells and neointima formation.

Authors:  Yung-Chieh Tsai; Sy-Ying Leu; Yi-Jen Peng; Yen-Mei Lee; Chih-Hsiung Hsu; Shen-Chieh Chou; Mao-Hsiung Yen; Pao-Yun Cheng
Journal:  J Cell Mol Med       Date:  2016-09-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.